CPI-0209 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Tulmimetostat

Filter by location:

Pittsburgh, Pennsylvania1 trial

CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Magee-Womens Research Institute / UPMC Magee Womens Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.